ANIP - ANIファ―マシュ―ティカルズ (ANI Pharmaceuticals Inc.) ANIファ―マシュ―ティカルズ

 ANIPのチャート


 ANIPの企業情報

symbol ANIP
会社名 ANI Pharmaceuticals Inc (ANIファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ANIファーマシューティカル(ANI Pharmaceuticals Inc.)は統合・専門的製薬会社である。同社はブランド医薬品とジェネリック医薬品の開発、製造、マーケティングに従事する。同社は抗癌剤(抗腫瘍剤)、ホルモンおよびステロイド、複合的製剤を提供する。同社はまた、他の製薬会社の請負製造を行う。製品には、ブランド医薬品とジェネリック医薬品を含む。ジェネリック医薬品はエリスロマイシンエチルコハク酸塩、メチルテストステロン(EEMT)を有するエステル化エストロゲン、エトドラクフェノフィブレート、フレカイニド、フルボキサミン、メタゾラミド、メトクロプラミドシロップニルタミド、ニモジピン、アヘンチンキ、オキシコドンカプセル、オキシコドン経口溶液、プロパフェノンおよびバンコマイシンなどを含む。ブランド製品にはコルテネーマ、インデラルLA、リトビッド、レグランおよびバンコシンが含まれる。同社の医薬品製造施設はミネソタ州ボーデットに位置する。   ANIファ―マシュ―ティカルズは米国の製薬会社。ブランドとジェネリックの医療用医薬品の開発、製造、販売に従事する。女性の性的健康、更年期障害、避妊と男性性腺機能低下症の治療用医薬品開発のほか、開発製品の対象は麻酔薬、抗がん薬、ホルモン・ステロイドおよび製剤を含む。本社はミネソタ州。   ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
本社所在地 210 Main Street West Baudette MN 56623 USA
代表者氏名 Robert E. Brown ロバートE.ブラウン
代表者役職名 Independent Chairman of the Board
電話番号 +1 218-634-3500
設立年月日 35278
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 173人
url www.anipharmaceuticals.com
nasdaq_url https://www.nasdaq.com/symbol/anip
adr_tso
EBITDA EBITDA(百万ドル) 62.04800
終値(lastsale) 54.83
時価総額(marketcap) 648570965.63
時価総額 時価総額(百万ドル) 656.49620
売上高 売上高(百万ドル) 189.20100
企業価値(EV) 企業価値(EV)(百万ドル) 806.10820
当期純利益 当期純利益(百万ドル) 13.49700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ANI Pharmaceuticals Inc revenues increased 15% to $93.8M. Net income applicable to common stockholders increased 31% to $5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Stock-based Compensation in SGA decrease of 3% to $2.7M (expense).

 ANIPのテクニカル分析


 ANIPのニュース

   Glycopeptide Antibiotics Market 2020 Global Industry Size, Growth, Segments with COVID-19 Impact Analysis || ANI Pharmaceuticals, Pfizer, Mylan N.V., Novartis AG, Allergan, Theravance Biopharma  2020/10/06 13:21:16 OpenPR
When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with decision making. This Glycopeptide Antibiotics Market analysis report gives out the data for industry about company profile, product
   The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs  2020/07/10 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
   ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass Estimates  2020/05/07 13:55:03 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of 16.85% and 0.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?  2020/05/01 15:50:10 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
   ANI Pharmaceuticals : Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL FDA Sets Prescription Drug User Fee Act (PDUFA) Goal Date of July 23, 2020 | MarketScreener  2020/04/13 12:43:03 MarketScreener
BAUDETTE, Minnesota - ANI Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has accepted its supplemental new drug application for Purified… | April 13, 2020
   The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs  2020/07/10 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
   ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass Estimates  2020/05/07 13:55:03 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of 16.85% and 0.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?  2020/05/01 15:50:10 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
   ANI Pharmaceuticals : Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL FDA Sets Prescription Drug User Fee Act (PDUFA) Goal Date of July 23, 2020 | MarketScreener  2020/04/13 12:43:03 MarketScreener
BAUDETTE, Minnesota - ANI Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has accepted its supplemental new drug application for Purified… | April 13, 2020
   ANI Pharmaceuticals : Announces Launch of Polyethylene Glycol 3350, 17g/Packet | MarketScreener  2020/04/01 21:47:11 MarketScreener
BAUDETTE, Minnesota - ANI Pharmaceuticals, Inc. today announced the launch of Polyethylene Glycol 3350, 17g/Packet . The current annual market for this over the counter product is… | April 1, 2020
   The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs  2020/07/10 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
   ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass Estimates  2020/05/07 13:55:03 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of 16.85% and 0.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?  2020/05/01 15:50:10 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
   ANI Pharmaceuticals : Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL FDA Sets Prescription Drug User Fee Act (PDUFA) Goal Date of July 23, 2020 | MarketScreener  2020/04/13 12:43:03 MarketScreener
BAUDETTE, Minnesota - ANI Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has accepted its supplemental new drug application for Purified… | April 13, 2020
   ANI Pharmaceuticals : Announces Launch of Polyethylene Glycol 3350, 17g/Packet | MarketScreener  2020/04/01 21:47:11 MarketScreener
BAUDETTE, Minnesota - ANI Pharmaceuticals, Inc. today announced the launch of Polyethylene Glycol 3350, 17g/Packet . The current annual market for this over the counter product is… | April 1, 2020

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ANIファ―マシュ―ティカルズ ANIP ANI Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)